JUL 21, 2020 12:35 PM PDT

Colorectal cancer screening kits delivered to you through the mail

New research published in the American Cancer Society’s CANCER says that improving screening rates for colorectal cancer could be implemented in a cost-effective manner via screening kits sent through the mail to Medicaid enrollees. 

While current medical standards recommend that adults ages 50-75 undergo screening for colorectal cancer by way of colonoscopies and at-home stool testing, over 33% of Americans within that age range do not comply with these recommendations. To make matters easier and more convenient, researchers have considered several methods to improve screening rates, including mailing screening reminders and mailing fecal immunochemical test (FIT) kits.

"By investing in sending the test kits with the reminder letters, health departments are expected to successfully screen more individuals for colorectal cancer at relatively low incremental costs, and Medicaid organizations are expected to actually save costs per additional person screened," said Dr. Wheeler. "This analysis provides strong evidence that health departments and payers like Medicaid can substantially improve colorectal cancer screening in low-income and medically underserved populations at a reasonable cost, even given limited budgets, through the implementation of mailed FIT programs." 

Colorectal cancer is one of the most commonly diagnosed cancers, and medically underserved populations are more likely to die from colorectal cancer than other groups, according to Dr. Wheeler.

Given the limitations that the pandemic has put on in-person encounters, this mailing system could be just the answer we need, says Alison Brenner, PhD, MPH. "Many aspects of preventive health care have moved to virtual delivery or mailed outreach delivery for the time being, and it is quite likely that some of these services will never fully return to in-person, visit-based delivery," said Dr. Brenner. "Decision-makers critically need guidance on how to allocate resources for virtual or mailed outreach care delivery." 

Photo: Pixabay

The authors conclude, writing, “The reminder + FIT alternative was cost-saving per additional Medicaid enrollee screened compared with the reminder‐only alternative from the Medicaid/state perspective and likely cost‐effective from the health clinic/facility perspective. The results also demonstrate that health departments and state Medicaid programs can efficiently mail FIT kits to large numbers of Medicaid enrollees to increase CRC screening completion.” 

Sources: CANCER, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 09, 2021
Cancer
Employing machine-learning to identify the biological languages of cancer and Alzheimer's
APR 09, 2021
Employing machine-learning to identify the biological languages of cancer and Alzheimer's
In a study published in the scientific journal PNAS, researchers from St. John's College and the  University of ...
APR 08, 2021
Cancer
What can modifiying cultured cells to act more like normal cells teach us about cancer?
APR 08, 2021
What can modifiying cultured cells to act more like normal cells teach us about cancer?
A team from the University of Louisville has developed a technique to make cell cultures act more like normal cells. Thi ...
MAY 26, 2021
Genetics & Genomics
Connecting Bacterial Genes to Human Disease
MAY 26, 2021
Connecting Bacterial Genes to Human Disease
This kind of research gets us closer to using fecal samples to get a snapshot of the microbiome, and make disease risk p ...
JUN 11, 2021
Cell & Molecular Biology
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
JUN 11, 2021
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
The immune system can detect and destroy pathogenic and cancerous cells, but sometimes those dangerous cells can evade t ...
JUN 26, 2021
Cancer
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
JUN 26, 2021
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
Research shows that obese patients with cancers including ovarian and melanoma may respond better to a certain kind of i ...
JUL 08, 2021
Cancer
Activating p53 May Boost Efficacy of Cancer Immunotherapy
JUL 08, 2021
Activating p53 May Boost Efficacy of Cancer Immunotherapy
Pharmacological activation of the p53 protein in cancer cells leads to an anti-tumor immune response in lab tests. These ...
Loading Comments...